NANDA-I, NOC, and NIC Linkages to SARS-Cov-2 (Covid-19): Part 1. Community Response.


Journal

International journal of nursing knowledge
ISSN: 2047-3095
Titre abrégé: Int J Nurs Knowl
Pays: United States
ID NLM: 101582422

Informations de publication

Date de publication:
Jan 2021
Historique:
pubmed: 5 6 2020
medline: 20 1 2021
entrez: 5 6 2020
Statut: ppublish

Résumé

We developed linkages using interoperable standardized nursing terminologies, NANDA International (NANDA-I) nursing diagnoses, Nursing Interventions Classification (NIC), and Nursing Outcomes Classification (NOC), to present initial guidance for the development of care plans focused on COVID-19 for nurses practicing in community or public health roles. Seven nurse experts identified the linkages of NANDA-I, NOC and NIC for our work related to the COVID-19 pandemic. A model was developed to guide the project. The first step in creating linkages focused on the identification of nursing diagnoses. Then, for each nursing diagnosis, outcomes aligned with all components of the diagnosis were categorized and a list of nursing interventions was selected. The experts used their clinical judgment to make final decisions on the linkages selected in this study. Two community level nursing diagnoses were identified as key problems appropriate for a pandemic related to COVID-19: Deficient Community Health and Ineffective Community Coping. For the nursing diagnosis Deficient Community Health, eight nursing outcomes and 12 nursing interventions were selected. In comparison for the nursing diagnosis, Ineffective Community Coping, nine nursing outcomes and 18 nursing interventions were identified. A total of40 concepts were identified for future development across the three classifications. The nursing diagnoses, outcomes and interventions selected during this linkage process provide knowledge to support the community challenged with responding to the COVID-19 pandemic, provide the opportunity to quantify the impact of nursing care, and enhance nursing practice by promoting the use of three standardized terminologies. NANDA-I, NOC and NIC linkages identified in this manuscript provide resources to support clinical decisions and care plan development for nurses practicing in the community.

Identifiants

pubmed: 32497413
doi: 10.1111/2047-3095.12291
pmc: PMC7300683
doi:

Types de publication

Journal Article

Langues

eng

Pagination

59-67

Informations de copyright

© 2020 NANDA International, Inc.

Références

J Community Health Nurs. 1991;8(3):137-46
pubmed: 1885961
J Nurs Adm. 2003 Nov;33(11):565-7
pubmed: 14608214
BMC Public Health. 2013 May 17;13:482
pubmed: 23679953
Health Educ Behav. 2012 Jun;39(3):364-72
pubmed: 22267868
J Transcult Nurs. 2005 Oct;16(4):289-97
pubmed: 16160191
Am J Community Psychol. 2009 Dec;44(3-4):213-20
pubmed: 19777338
Int J Nurs Knowl. 2020 Oct;31(4):246-252
pubmed: 32181604
J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238
Am J Public Health. 2019 Jun;109(6):832-833
pubmed: 31067091

Auteurs

Sue Moorhead (S)

Associate Professor and Director for the Center for Nursing Classification & Clinical Effectiveness, College of Nursing, University of Iowa, Iowa City, IA.

Tamara Gonçalves Rezende Macieira (TGR)

Postdoctoral Associate, College of Nursing, University of Florida, Gainesville, FL.

Karen Dunn Lopez (KD)

Associate Professor and Director for Research for Center for Nursing Classification & Clinical Effectiveness, College of Nursing, University of Iowa, Iowa City, IA.

Vanessa Monteiro Mantovani (VM)

Graduate Program in Nursing, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Elizabeth Swanson (E)

Associate Professor Emerita, College of Nursing, University of Iowa, Iowa City, IA.

Cheryl Wagner (C)

Adjunct Assistant Professor, College of Nursing, University of Iowa, Iowa City, IA.

Noriko Abe (N)

Coordinator for the Center for Nursing Classification and Clinical Effectiveness, College of Nursing, University of Iowa, Iowa City, IA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH